BioInvent International AB (Nasdaq Stockholm: BINV) is a clinical-stage biotech company that discovers and develops novel and first-in-class immuno-modulatory antibodies for cancer therapy, with currently three drug candidates in four ongoing clinical programs in Phase l/ll trials for the treatment of hematological cancer and solid tumors, respectively.

Biotechnology

BioInvent International

BioInvent International's headquarters in Lund, Sweden

Martin Welschof

Stefan Ericsson

Björn Frendéus

Sylvie Ryckebusch

Marie Moores

Andres Mcallister

Kristoffer Bissessar

Thomas Hecht

Martin Pålsson

Erik Esveld

Natalie Berner

Nanna Lüneborg

Leonard Kruimer

Vincent Ossipow

Bernd Seizinger

The Research and Development team at BioInvent International is dedicated to advancing the company’s mission of discovering and developing innovative immuno-modulatory antibodies for cancer treatment. Comprising a diverse range of scientists and engineers, the team focuses on researching and optimizing therapeutic candidates, developing manufacturing processes, and conducting preclinical studies to ensure successful progress through clinical trials. Their collective expertise drives the pipeline of novel therapies aimed at improving outcomes for patients with hematological cancer and solid tumors.

Research and Development

The Quality Assurance and Control team at BioInvent International is responsible for ensuring that all processes and products meet rigorous quality standards throughout the clinical development of novel immuno-modulatory antibodies. This team conducts thorough inspections, implements quality management systems, and performs analytical testing to guarantee compliance with regulatory requirements and internal standards, ultimately supporting the safe and effective advancement of drug candidates in clinical trials.

Quality Assurance and Control

The Leadership Team at BioInvent International is responsible for guiding the strategic direction and operational execution of the company’s clinical-stage development of innovative immuno-modulatory antibodies for cancer therapy. Comprising key executives from various functions, including medical, scientific, operational, financial, and business development, the team collaborates to ensure effective decision-making, resource allocation, and alignment of clinical programs with corporate goals to drive advancements in cancer treatment.

Leadership Team

The Project Management Team at BioInvent International oversees the planning, execution, and optimization of clinical development projects for innovative antibody therapies. They coordinate cross-functional activities, manage timelines and resources, and ensure compliance with regulatory requirements, all while collaborating closely with clinical, manufacturing, and strategic teams to drive successful outcomes in clinical trials targeting hematological cancer and solid tumors.

BioInvent International

Org chart

Board & advisors

Teams

Research and Development

Quality Assurance and Control

Leadership Team

Project Management Team

Offices

BioInvent International

Org chart

Board & advisors

Teams

Research and Development

Quality Assurance and Control

Leadership Team

Project Management Team

Offices

Related companies